Chrystal Louis
Technik-/Wissenschafts-/F&E-Leiter bei TSCAN THERAPEUTICS, INC.
Aktive Positionen von Chrystal Louis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TSCAN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.04.2024 | - |
Karriereverlauf von Chrystal Louis
Ehemalige bekannte Positionen von Chrystal Louis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.11.2022 | 01.03.2024 |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Corporate Officer/Principal | 01.07.2020 | 01.11.2022 |
CELGENE | Corporate Officer/Principal | 01.10.2016 | 01.01.2019 |
Ausbildung von Chrystal Louis
Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
Tulane University School of Medicine | Doctorate Degree |
Southwestern University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TSCAN THERAPEUTICS, INC. | Health Technology |
ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Chrystal Louis
- Erfahrung